Soledad Retamozo, Chiara Baldini, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Benjamin A Fisher, Jacques-Eric Gottenberg, Gabriela Hernández-Molina, Agnes Kocher, Belchin Kostov, Aike A Kruize, Thomas Mandl, Wan-Fai Ng, Raphaèle Seror, Yehuda Shoenfeld, Antoni Sisó-Almirall, Athanasios G Tzioufas, Arjan Vissink, Claudio Vitali, Simon J Bowman, Xavier Mariette, Manuel Ramos-Casals, Pilar Brito-Zerón
Primary Sjögren's syndrome (SjS) is a systemic autoimmune disease most commonly diagnosed in middle-aged women. Although the disease can occur at all ages, it is diagnosed between 30 and 60 years of age in two-thirds of patients. In more than 20% of cases, the people are older than 65 years. In this review, we focus on the therapeutic management of primary SjS in older patients, following the recently published 2020 European League Against Rheumatism (EULAR) recommendations for the management of the disease with topical and systemic therapies...
February 23, 2021: Drugs & Aging